EdgarLookup
SC 13G

PROTAGENIC THERAPEUTICS, INC. SC13G

Company
Protagenic Therapeutics, Inc.\new
Filed
February 2, 2018
Accession Number
0001393825-18-000041

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →